Kinder und Rheuma

H. Michels; K. Minden

doi:10.1055/s-0037-1618027

Arthritis und Rheuma, Table of Contents

Arthritis und Rheuma 2010; 30(05): 266-277
DOI: 10.1055/s-0037-1618027

Kinderorthopädie

Schattauer GmbH

Kinder und Rheuma

Was passiert am Skelett?How affects juvenile idiopathic arthritis the musculoskeletal system?What happens on the skeleton?

H. Michels

¹Deutsches Zentrum für Kinder- und Jugendrheumatologie Garmisch-Partenkirchen

,

K. Minden

²Deutsches Rheumaforschungszentrum Berlin, Abteilung Epidemiologie und Universitätskinderklinik Charité, Campus Virchow, Abteilung Kinder- und Jugendrheumatologie, Berlin

› Author Affiliations

Abstract

Zusammenfassung

Eine chronische Gelenkentzündung trifft bei Kindern auf einen sich entwickelnden Organismus. Deshalb gehen mögliche Konsequenzen einer juvenilen idiopathischen Arthritis (JIA) weit über eine alleinige Gelenkschädigung hinaus. Am Bewegungsapparat können Veränderungen des gesamten Bewegungsablaufs, Gelenkfehlstellungen, allgemeine und gelenkspezifische lokale Wachstumsstörungen, Verminderungen von Muskelmasse und -kraft sowie von Knochenmasse, -geometrie und -festigkeit beobachtet werden. Eine Störung der gesamten statomotorischen Entwicklung des Kindes kann die Folge der Arthritis sein. Diese Veränderungen können bis ins Erwachsenenalter persistieren und zu einer erheblichen Komorbidität der Betroffenen beitragen. Insofern stellen die Überwachung des gesamten Skelettsystems und – falls nötig – therapeutische Interventionen sehr wichtige Aspekte in der Betreuung von Kindern mit JIA dar.

Summary

A chronic arthritis in children hits an organism in development and maturation. Possible consequences of juvenile idiopathic arthritis (JIA) go thus far beyond solely joint damage. Observed alterations of the musculoskeletal system include changes of movement patterns and postures, joint deformities, general and specific local growth disturbances, reductions in muscle mass and strength, and in bone mass, geometry and strength as well. The entire statomotoric development of the child may be affected by the arthritis. Such changes can persist into adulthood and contribute to a significant co-morbidity of those affected. Therefore, a close monitoring of the entire skeletal system and – if necessary – therapeutic interventions are very important aspects in the care of children with JIA.

Schlüsselwörter

Juvenile idiopathische Arthritis - Knochen - Wachstum - Osteoporose

Keywords

Juvenile idiopathic arthritis - bone - growth - osteoporosis

Full Text

References

Literatur
1 Angeles-Han S, Prahalad S. The genetics of juvenile idiopathic arthritis: what is new in 2010?. Curr Rheumatol Rep 2010; 12: 87-93.
2 Ansell BM. Uncommon radiological features of chronic arthritis in childhood: a review. J R Soc Med 1981; 74: 904-908.
3 Bechtold S, Ripperger P, Dalla Pozza R. et al. Musculoskeletal and functional muscle-bone analysis in children with rheumatic disease using peripheral quantitative computed tomography. Osteoporos Int 2005; 16: 757-763.
4 Billiau AD, Loop M, Le PQ. et al. Etanercept improves linear growth and bone mass acquisition in MTX-resistant polyarticular-course juvenile idiopathic arthritis. Rheumatology (Oxford) 2010; 49: 1550-1558.
5 Burnham JM, Shults J, Weinstein R. et al. Childhood onset arthritis is associated with an increased risk of fracture: a population based study using the General Practice Research Database. Ann Rheum Dis 2006; 65: 1074-1079.
6 Cassidy JT, Petty R. Chronic arthritis in childhood. Radiologic examination. In: Cassidy JT, Petty RE, Laxer RM, Lindsley CB. eds. Textbook of Pediatric Rheumatology. 5th ed.. Philadelphia: Elsevier; 2005: 226-231.
7 Davies UM, Rooney M, Preece MA. et al. Treatment of growth retardation in juvenile chronic arthritis with recombinant human growth hormone. J Rheumatol 1994; 21: 153-158.
8 Flato B, Lien G, Smerdel A. et al. Prognostic factors in juvenile rheumatoid arthritis: a case-control study revealing early predictors and outcome after 14.9 years. J Rheumatol 2003; 30: 386-393.
9 French AR, Mason T, Nelson AM. et al. Osteopenia in adults with a history of juvenile rheumatoid arthritis. A population based study. J Rheumatol 2002; 29: 1065-1070.
10 Fried JA, Athreya B, Gregg JR. et al. The cervical spine in juvenile rheumatoid arthritis. Clin Orthop Relat Res 1983; 179: 102-106.
11 Gattorno M, Gerloni V, Morando A. et al. Synovial membrane expression of matrix metalloproteinases and tissue inhibitor 1 in juvenile idiopathic arthritides. J Rheumatol 2002; 29: 1774-1779.
12 Grom AA, Hirsch R. T-cell and T-cell receptor abnormalities in the immunopathogenesis of juvenile rheumatoid arthritis. Curr Opin Rheumatol 2000; 12: 420-424.
13 Häfner R. Bedeutung der bildgebenden Verfahren für Diagnose und Verlauf der juvenilen Arthritis – Unterschiede zum Erwachsenen. Akt Rheumatol 2002; 27: 253-258.
14 Henderson CJ, Specker BL, Sierra RI, Campaigne BN. et al. Total-body bone mineral content in noncorticosteroid-treated postpubertal females with juvenile rheumatoid arthritis: frequency of osteopenia and contributing factors. Arthritis Rheum 2000; 43: 531-540.
15 Kropp A, Kettner HO, Michels H. Anakinra bei zwei Kindern mit therapieresistenter systemischer juveniler idiopathischer Arthritis. arthritis + rheuma 2006; 26: 109-112.
16 Lien G, Flato B, Haugen M. et al. Frequency of osteopenia in adolescents with early-onset juvenile idiopathic arthritis: a long-term outcome study of one hundred five patients. Arthritis Rheum 2003; 48: 2214-2223.
17 Long AR, Rouster-Stevens KA. The role of exercise therapy in the management of juvenile idiopathic arthritis. Curr Opin Rheumatol 2010; 22: 213-217.
18 MacRae VE, Farquharson C, Ahmed SF. The pathophysiology of the growth plate in juvenile idiopathic arthritis. Rheumatology (Oxford) 2006; 45: 11-19.
19 MacRae VE, Wong SC, Farquharson C, Ahmed SF. Cytokine actions in growth disorders associated with pediatric chronic inflammatory diseases. Int J Mol Med 2006; 18: 1011-1018.
20 Magni-Manzoni S, Rossi F, Pistorio A. et al. Prognostic factors for radiographic progression, radiographic damage, and disability in juvenile idiopathic arthritis. Arthritis Rheum 2003; 48: 3509-3517.
21 Mason T, Reed AM, Nelson AM. et al. Frequency of abnormal hand and wrist radiographs at time of diagnosis of polyarticular juvenile rheumatoid arthritis. J Rheumatol 2002; 29: 2214-2218.
22 Minden K, Niewerth M, Listing J. et al. Long-term outcome in patients with juvenile idiopathic arthritis. Arthritis Rheum 2002; 46: 2392-2401.
23 Mushtaq T, Ahmed SF. The impact of corticosteroids on growth and bone health. Arch Dis Child 2002; 87: 93-96.
24 Niehues T, Feyen O, Telieps T. Vorstellungen zur Pathogenese der juvenilen idiopathischen Arthritis. Z Rheumatol 2008; 67: 111-120.
25 Nishimoto N, Kishimoto T. Interleukin 6: from bench to bedside. Nat Clin Pract Rheumatol 2006; 2: 619-626.
26 Oen K, Reed M, Malleson PN. et al. Radiologic outcome and its relationship to functional disability in juvenile rheumatoid arthritis. J Rheumatol 2003; 30: 832-840.
27 Packham JC, Hall MA. Long-term follow-up of 246 adults with juvenile idiopathic arthritis: functional outcome. Rheumatology (Oxford) 2002; 41: 1428-1435.
28 Pepmueller PH, Cassidy JT, Allen SH, Hillman LS. Bone mineralization and bone mineral metabolism in children with juvenile rheumatoid arthritis. Arthritis Rheum 1996; 39: 746-757.
29 Roth J, Linge M, Tzaribachev N. et al. Musculoskeletal abnormalities in juvenile idiopathic arthritis – a 4-year longitudinal study. Rheumatology (Oxford) 2007; 46: 1180-1184.
30 Roth J, Palm C, Scheunemann I. et al. Musculoskeletal abnormalities of the forearm in patients with juvenile idiopathic arthritis relate mainly to bone geometry. Arthritis Rheum 2004; 50: 1277-1285.
31 Schmeling H, Seliger E, Horneff G. Growth reconstitution in juvenile idiopathic arthritis treated with etanercept. Clin Exp Rheumatol 2003; 21: 779-784.
32 Sherry DD, Stein LD, Reed AM. et al. Prevention of leg length discrepancy in young children with pauciarticular juvenile rheumatoid arthritis by treatment with intraarticular steroids. Arthritis Rheum 1999; 42: 2330-2334.
33 Simon D. Management of growth retardation in juvenile idiopathic arthritis. Horm Res 2007; 68 (Suppl. 05) 122-125.
34 Stagi S, Masi L, Capannini S. et al. Cross-sectional and Longitudinal Evaluation of Bone Mass in Children and Young Adults with Juvenile Idiopathic Arthritis: The Role of Bone Mass Determinants in a Large Cohort of Patients. J Rheumatol. 2010 Jun 1. [Epub ahead of print]
35 Truckenbrodt H, Häfner R. Allgemeine und lokale Wachstumsstörungen bei chronischer Arthritis im Kindesalter. Schweiz Med Wochenschr 1991; 121: 608-620.
36 Turnley AM. Role of SOCS2 in growth hormone actions. Trends Endocrin Metab 2005; 16: 53-58.
37 Tzaribachev N, Weber D, Horger M. Juvenile idiopathische Arthritis: Der leise Zerstörer kindlicher Kiefergelenke. Z Rheumatol 2010; 69: 124-129.
38 van den Ham HJ, de Jager W, Bijlsma JW. et al. Differential cytokine profiles in juvenile idiopathic arthritis subtypes revealed by cluster analysis. Rheumatology (Oxford) 2009; 48: 899-905.
39 WHO Study Group. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. WHO Tech Rep Ser 1994; 843: 1-129.
40 Zak M, Hassager C, Lovell DJ. et al. Assessment of bone mineral density in adults with a history of juvenile chronic arthritis: a cross-sectional long-term followup study. Arthritis Rheum 1999; 42: 790-798.